Press Release: Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophilia

https://ift.tt/8VSJeXR

Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophilia



from Sanofi - Aventis Groupe https://ift.tt/4EogUx8
via IFTTT

Post a Comment

0 Comments